title: Prolonged upper airway instability in the parenteral use of benzodiazepine with levomepromazine.
authors.forename: K
authors.initials: K
authors.lastname: Hatta
authors.forename: T
authors.initials: T
authors.lastname: Takahashi
authors.forename: H
authors.initials: H
authors.lastname: Nakamura
authors.forename: S
authors.initials: S
authors.lastname: Fujii
authors.forename: H
authors.initials: H
authors.lastname: Yamashiro
authors.forename: N
authors.initials: N
authors.lastname: Asukai
authors.forename: Y
authors.initials: Y
authors.lastname: Yonezawa
mesh_terms: D000293:Adolescent; D000328:Adult; D014151:Anti-Anxiety Agents / Q000008:administration & dosage / Q000009:adverse effects*; D014150:Antipsychotic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D001049:Apnea / Q000139:chemically induced*; D004359:Drug Therapy, Combination; D005445:Flunitrazepam / Q000008:administration & dosage / Q000009:adverse effects*; D006801:Humans; D008728:Methotrimeprazine / Q000008:administration & dosage / Q000009:adverse effects*; D008875:Middle Aged; D010101:Oxygen Consumption / Q000187:drug effects*; D012119:Respiration / Q000187:drug effects; D012559:Schizophrenia / Q000188:drug therapy
chemical_list: D014151:Anti-Anxiety Agents; D014150:Antipsychotic Agents; D005445:Flunitrazepam; D008728:Methotrimeprazine